A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10-14 years-Reference-Cited by-同舟云学术

A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10-14 years

Published:2019-07-17 Issue:7-8 Volume:15 Page:1970-1979
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Schwarz Tino F.¹^ORCID,Huang Li-Min²,Valencia Alejandra³,Panzer Falko⁴^ORCID,Chiu Cheng-Hsun⁵,Decreux Annabelle⁶,Poncelet Sylviane⁶^ORCID,Karkada Naveen⁶^ORCID,Folschweiller Nicolas⁶^ORCID,Lin Lan⁶^ORCID,Dubin Gary⁷⁸,Struyf Frank⁶^ORCID

Affiliation:

1. Institute of Laboratory Medicine and Vaccination Centre, Klinikum Würzburg Mitte, Standort Juliusspital, Würzburg, Germany

2. Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan

3. Department of Pediatrics, Fundación de Santa Fe de Bogotá, Bogota, Colombia

4. Practice for Pediatric and Adolescent Medicine, Mannheim, Germany

5. Department of Pediatrics, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan

6. GSK, Wavre/Rixensart, Belgium

7. GSK, King of Prussia, PA, USA

8. Takeda Pharmaceuticals, Glattpark-Opfikon, Zurich, Switzerland

Funder

GlaxoSmithKline Biologicals SA

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://tandfonline.com/doi/pdf/10.1080/21645515.2019.1625644

Reference47 articles.

1. Bruni L, Barrionuevo-Rosas L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J, Bosch F, de Sanjosé S Human papillomavirus and related diseases in the world. Summary Report; 2017 July 27 [accessed 2018 Nov 22]. http://hpvcentre.net/statistics/reports/XWX.pdf.

2. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

3. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

4. High incidence of cervical human papillomavirus infection in women during their first sexual relationship

5. HPV vaccine: an overview of immune response, clinical protection, and new approaches for the future

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Looking Back, Moving Forward: Challenges and Opportunities for Global Cervical Cancer Prevention and Control;Viruses;2024-08-25

2. Human papillomavirus vaccination coverage among young women in the three sub-Saharan African countries using Demographic and Health Surveys data;Human Vaccines & Immunotherapeutics;2024-07

3. Immunogenicity of quadrivalent human papillomavirus vaccine among Alaska Native children aged 9–14 years at 5 years after vaccination;Vaccine;2024-05

4. Cervical cancer prevention by vaccination: review;Frontiers in Oncology;2024-04-23

5. HPV and Cervical Cancer: Molecular and Immunological Aspects, Epidemiology and Effect of Vaccination in Latin American Women;Viruses;2024-02-21